Description
390 Matrix Metalloproteinases Substrate 13
| Catalog number: | B2011277 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | 1675.9 g/mol |
| Supplied as: | Lyophilized |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20 C |
| Keywords: | 390 MMP Substrate 13, NFF-3, Matrix Metalloproteinases |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Khalil HH, Osman HA, Teleb M, Darwish AI, Abu-Serie MM, Khattab SN, Haiba NS. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma ChemMedChem. 2021 Dec 14;16(24):3701-3719.
- Hardy E, Fernandez-Patron C. Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis Biomolecules. 2021 Mar 6;11(3):390.
- Gabriel CER, Nguyen TT, Gargano EM, Fisher JF, Chang M, Mobashery S. Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor (R)-ND-336 ACS Pharmacol Transl Sci. 2021 Apr 6;4(3):1204-1213.
- Li J, Wang JM, Liu YH, Zhang Z, Han N, Wang JY, Xue SH, Wang P. [Effect of microRNA-106b on the invasion and proliferation of trophoblasts through targeting MMP-2] Zhonghua Fu Chan Ke Za Zhi. 2017 May 25;52(5):327-332.
- Yadav MR, Murumkar PR, Zambre VP. Advances in studies on collagenase inhibitors Exp Suppl. 2012;103:83-135.
- Ieguchi K, Tomita T, Takao T, Omori T, Mishima T, Shimizu I, Tognolini M, Lodola A, Tsunoda T, Kobayashi S, Wada S, Maru Y. Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions Int J Mol Sci. 2021 Mar 1;22(5):2480.
- Watanabe N, Ikeda U. Matrix metalloproteinases and atherosclerosis Curr Atheroscler Rep. 2004 Mar;6(2):112-20.
- Krengel S, Alexander M, Brinckmann J, Tronnier M. MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light J Cutan Pathol. 2002 Aug;29(7):390-6.
- Kiiski H, Lngsj J, Tenhunen J, Ala-Peijari M, Huhtala H, Hmlinen M, Moilanen E, Peltola J. S100B, NSE and MMP-9 fail to predict neurologic outcome while elevated S100B associates with milder initial clinical presentation after aneurysmal subarachnoid hemorrhage J Neurol Sci. 2018 Jul 15;390:129-134.
